Stevanato Group S.p.A. (NYSE:STVN) Receives Average Rating of “Buy” from Analysts

Shares of Stevanato Group S.p.A. (NYSE:STVN) have been given an average rating of “Buy” by the seven brokerages that are covering the firm, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold rating, three have given a buy rating and two have issued a strong buy rating on the company.

Several research firms have recently weighed in on STVN. KeyCorp decreased their price target on shares of Stevanato Group from $37.00 to $32.00 and set an “overweight” rating on the stock in a research note on Thursday, March 5th. Citigroup cut their price objective on shares of Stevanato Group from $32.00 to $26.00 and set a “buy” rating for the company in a research report on Thursday, March 5th. Morgan Stanley cut their price objective on shares of Stevanato Group from $24.00 to $19.00 and set an “equal weight” rating for the company in a research report on Friday, March 6th. Wolfe Research began coverage on shares of Stevanato Group in a research report on Tuesday, June 2nd. They set an “outperform” rating and a $21.00 price objective for the company. Finally, Weiss Ratings upgraded shares of Stevanato Group from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Thursday, June 18th.

Institutional Investors Weigh In On Stevanato Group

Hedge funds and other institutional investors have recently bought and sold shares of the company. GW&K Investment Management LLC increased its position in Stevanato Group by 76.2% during the fourth quarter. GW&K Investment Management LLC now owns 2,440 shares of the company’s stock worth $49,000 after purchasing an additional 1,055 shares during the last quarter. Fifth Third Bancorp increased its position in shares of Stevanato Group by 22.6% during the first quarter. Fifth Third Bancorp now owns 4,196 shares of the company’s stock valued at $58,000 after acquiring an additional 773 shares during the last quarter. State of Wyoming increased its position in shares of Stevanato Group by 39,216.7% during the second quarter. State of Wyoming now owns 2,359 shares of the company’s stock valued at $58,000 after acquiring an additional 2,353 shares during the last quarter. Quantbot Technologies LP acquired a new stake in shares of Stevanato Group during the third quarter valued at about $68,000. Finally, Tower Research Capital LLC TRC increased its position in shares of Stevanato Group by 1,268.7% during the second quarter. Tower Research Capital LLC TRC now owns 4,585 shares of the company’s stock valued at $112,000 after acquiring an additional 4,250 shares during the last quarter.

Stevanato Group Stock Performance

NYSE:STVN opened at €18.36 on Tuesday. The company’s 50-day moving average price is €17.41 and its 200-day moving average price is €17.26. The company has a current ratio of 1.63, a quick ratio of 1.11 and a debt-to-equity ratio of 0.21. The company has a market cap of $5.56 billion, a P/E ratio of 31.11, a P/E/G ratio of 1.59 and a beta of 0.78. Stevanato Group has a twelve month low of €12.89 and a twelve month high of €28.00.

Stevanato Group (NYSE:STVN) last posted its quarterly earnings results on Friday, May 8th. The company reported €0.11 earnings per share for the quarter, missing the consensus estimate of €0.12 by (€0.01). The business had revenue of €273.57 million during the quarter. Stevanato Group had a return on equity of 10.27% and a net margin of 11.76%.The company’s quarterly revenue was up 6.6% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.10 earnings per share. On average, sell-side analysts forecast that Stevanato Group will post 0.68 earnings per share for the current fiscal year.

Stevanato Group Cuts Dividend

The company also recently disclosed an annual dividend, which will be paid on Wednesday, July 29th. Investors of record on Thursday, June 11th will be given a dividend of $0.054 per share. This represents a yield of 31.0%. The ex-dividend date is Thursday, June 11th.

Stevanato Group Company Profile

Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.

In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.